北美美容整形外科设备市场 – 行业趋势及 2028 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

北美美容整形外科设备市场 – 行业趋势及 2028 年预测

  • Medical Devices
  • Published Report
  • Jun 2021
  • North America
  • 350 页面
  • 桌子數: 77
  • 图号: 43

北美美容与整形外科设备市场,按类型(乳房植入物/乳房植入物、身体植入物和定制植入物)、原材料(聚合物、金属和生物材料)、最终用户(诊所、医院、皮肤​​科诊所等)、分销渠道(直接招标、零售药店)、国家(美国、加拿大、墨西哥)划分的行业趋势和预测到 2028 年。

北美美容整形外科器械市场

市场分析与洞察:北美美容整形外科设备市场

美容与整容手术设备市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析,在 2021 年至 2028 年的预测期内,市场将以 7.0% 的复合年增长率增长,预计到 2028 年将达到 19.8542 亿美元。美容与整容手术设备产品的使用量增加、老年人口的增长是预测期内推动市场需求的主要驱动力。

医疗基础设施的进步有效地促进了美容和整容手术设备市场的增长。然而,美容和整容手术设备相关的并发症可能会阻碍美容和整容手术设备市场未来的增长。主要市场参与者的合作和收购为美容和整容手术设备市场的增长提供了机会。

由于全球老年人口不断增长,美容整形手术设备市场在全球范围内发展迅猛。美容整形手术设备产品种类繁多,满足了外科医生在美容整形手术期间的需求。技术进步的加快促使美容整形手术设备市场的主要市场参与者推出更多产品。推动该市场增长的主要因素包括人均收入的提高、技术进步和人们对乳房重建手术的认识不断提高等,而阻碍该市场增长的因素包括产品召回率的提高和高昂的治疗费用等。

美容整形外科器械市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息,分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况,请联系我们获取分析师简报,我们的团队将帮助您创建收入影响解决方案,以实现您的预​​期目标。

北美美容整形外科器械市场

北美美容整形外科器械市场范围和市场规模

美容整形外科器械市场根据类型、原材料、最终用户和分销渠道进行细分。细分市场的增长有助于您分析细分市场的增长空间和进入市场的策略,并确定您的核心应用领域和目标市场的差异。

  • 根据类型,美容整形手术器械市场分为乳房植入物/乳房植入物、身体植入物和定制植入物。2021 年,由于全球乳腺癌的患病率和发病率不断上升,乳房植入物/乳房植入物占据了市场主导地位。
  • 根据原材料,美容整形手术器械市场分为聚合物、金属和生物材料。2021 年,由于医疗保健支出的增加和各种聚合物美容整形手术器械需求的增加,聚合物将占据市场主导地位。
  • 根据最终用户,美容整形手术设备市场分为诊所、医院、皮肤​​科诊所和其他。2021 年,医院部门占据市场主导地位,因为它为患者提供最佳且易于获得的医疗保健服务。
  • 根据分销渠道,美容整形外科设备市场分为直接招标和零售药店。2021 年,直接招标部分占据市场主导地位,因为直接招标占据最大的市场份额,同时复合年增长率最高,因为大多数服务提供商从制造商处购买设备,并且人们注意到直接销售的收入更高;因此它在市场上具有影响力并且正在增长。

 美容整形外科器械市场国家级分析

对美容及整容手术设备市场进行了分析,并按上述类型、原材料、最终用户和分销渠道提供了市场规模信息。

北美美容与整容手术设备市场报告涵盖的国家包括美国、加拿大和墨西哥。

由于北美地区患者大量采用美容和整容手术设备,预计北美将占据市场主导地位。由于该地区主要市场参与者的存在感增加,美国在市场上占据主导地位并引领北美市场的增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。

美容整形外科设备市场收购兼并不断增多,为企业创造新机遇

美容和整容手术设备市场还为您提供每个国家增长的详细市场分析。此外,它还提供有关主要市场参与者和初创公司之间收购和协议的数据。此外,研发活动对美容和整容手术设备市场增长速度的影响越来越大。数据适用于 2010 年至 2019 年的历史时期。

竞争格局和美容整形手术设备市场份额分析

 美容整形外科器械市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对美容整形外科器械市场的关注有关。

报告中涉及的主要参与者包括强生服务公司、艾尔建(abbvie INC. 的子公司)、Airxpanders, Inc.、Bonashmedical、Cereplas、Coloplast Corp、DPS Technology Development Ltd、Establishment Labs SA、GC Aesthetics、Hansbiomed co. Ltd、Ideal Implant Incorporated、Implantech、Koken Co., Ltd.、Laboratoires Arion、PMT Corporation、Polytech Health & Aesthetics Gmbh、Rigicon Inc.、Sebbin、上海康宁医疗用品有限公司、Sientra, Inc.、Silimed、Stryker、Surgisil LLP、Wanhe、Xilloc Medical BV、Integra Lifesciences、Lipoelastic AS、Defygravity 和 Karl Storz Se & Co. Kg 等国内和北美参与者。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

主要参与者不断增长的合同、合作伙伴关系和收购加速了美容及整形外科设备市场的增长。

例如,

  • 2020 年 5 月,AbbVie Inc. 完成了对 Allergan 的收购。此次收购帮助 AbbVie Inc. 扩大了其产品市场和未来需求,因为此次收购整合了两家公司的产品组合,从而增强了其业务。
  • 2019 年 6 月, Establishment Labs SA 与从事制造的 Ipomia 公司合作,打造了一系列胸罩,即专为接受 Motiva 假体隆胸手术的女性设计的术后胸罩。此次新合作提高了该公司在市场上的信誉。

市场参与者的合作、合资和其他策略正在扩大公司在美容和整容手术设备市场的影响力,这也为组织的增长速度带来了好处。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA BREAST RECONSTRUCTION MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

3.1 MARKET END USER COVERAGE GRID

4 PREMIUM INSIGHT

5 BREAST IMPLANTS FROM BREAST CANCER CASES (2020)

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING PREVALENCE & INCIDENCE OF BREAST CANCER

6.1.2 INCREASING AESTHETIC APPEARANCE

6.1.3 GROWING AWARENESS ABOUT RECONSTRUCTIVE BREAST SURGERIES

6.1.4 INCREASING TECHNOLOGY ADVANTAGES IN BREAST RECONSTRUCTIVE PROCEDURES

6.2 RESTRAINTS

6.2.1 PRODUCT RECALL

6.2.2 HIGH COST OF TREATMENT

6.3 OPPORTUNITIES

6.3.1 INNOVATION AND ADVANCEMENT

6.3.2 INCREASING MEDICAL TOURISM

6.4 CHALLENGE

6.4.1 POST-SURGERY COMPLICATION

6.4.2 EMERGENCE OF COVID-19

7 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TYPE

7.1 OVERVIEW

7.2 BREAST IMPLANTS

7.2.1 SILICONE

7.2.2 SALINE

7.3 TISSUE EXPANDERS

7.4 IMPLANTS ACCESSORIES

8 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TECHNOLOGY

8.1 OVERVIEW

8.2 INFRAMAMMARY

8.3 TRANS-AXILLARY

8.4 PERI-AREOLAR

8.5 TRANSUMBILICAL

9 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY RECONSTRUCTION SHAPE

9.1 OVERVIEW

9.2 ROUND IMPLANT SHAPE

9.3 ANATOMICAL IMPLANT SHAPE

9.4 ROUND EXPANDER SHAPE

9.5 ANATOMICAL EXPANDER SHAPE

10 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY PLACEMENT

10.1 OVERVIEW

10.2 DUAL-PLANE INSERTION

10.3 SUBGLANDULAR INSERTION

10.4 SUBMUSCULAR INSERTION

11 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY END USER

11.1 OVERVIEW

11.2 HOSPITAL

11.3 CLINICS

11.4 AMBULATORY SURGICAL CENTERS

12 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW

12.2 DIRECT TENDER

12.3 RETAIL

13 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY GEOGRAPHY

13.1 NORTH AMERICA

13.1.1 U.S.

13.1.2 CANADA

13.1.3 MEXICO

14 NORTH AMERICA BREAST RECONSTRUCTION MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

15 COMPANY PROFILE

15.1 JOHNSON & JOHNSON SERVICES, INC.

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENT

15.2 ALLERGAN (A SUBSIDIARY OF ABBVIE INC.)

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 GC AESTHETICS

15.3.1 COMPANY SNAPSHOT

15.3.2 COMPANY SHARE ANALYSIS

15.3.3 PRODUCT PORTFOLIO

15.3.4 RECENT DEVELOPMENTS

15.4 ESTABLISHMENT LABS S.A.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENTS

15.5 INTEGRA LIFESCIENCES

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENTS

15.6 AIRXPANDERS, INC.

15.6.1 COMPANY SNAPSHOT

15.6.2 PRODUCT PORTFOLIO

15.6.3 RECENT DEVELOPMENT

15.7 CEREPLAS

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 RECENT DEVELOPMENT

15.8 DEFYGRAVITY

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 DPS TECHNOLOGY DEVELOPMENT LTD

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENTS

15.1 HANSBIOMED CO. LTD

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENT

15.11 IDEAL IMPLANT INCORPORATED

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENT

15.12 KOKEN CO.,LTD.

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 KARL STORZ SE & CO. KG

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENTS

15.14 LABORATOIRES ARION

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 LIPOELASTIC A.S.

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENTS

15.16 PMT CORPORATION

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENT

15.17 POLYTECH HEALTH & AESTHETICS GMBH

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENTS

15.18 SEBBIN

15.18.1 COMPANY SNAPSHOT

15.18.2 PRODUCT PORTFOLIO

15.18.3 RECENT DEVELOPMENT

15.19 SHANGHAI KANGNING MEDICAL SUPPLIES LTD.

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENT

15.2 SIENTRA, INC.

15.20.1 COMPANY SNAPSHOT

15.20.2 REVENUE ANALYSIS

15.20.3 PRODUCT PORTFOLIO

15.20.4 RECENT DEVELOPMENTS

15.21 WANHE

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

表格列表

TABLE 1 BREAST CANCER RATE IN WORLD IN 2018

TABLE 2 BREAST CANCER RATE IN NORTH AMERICA IN 2018

TABLE 3 NEW CASES OF BREAST CANCER BY AGE GROUP IN AMERICA, 2017

TABLE 4 AESTHETIC BREAST SURGERY PROCEDURE IN AMERICA

TABLE 5 AESTHETIC BREAST SURGERY PROCEDURE IN SOME COUNTRIES OF LATIN AMERICA IN THE YEAR 2019

TABLE 6 APPROXIMATE COST OF BREAST AUGMENTATION VARIATIONS IN SAO PAULO, BRAZIL

TABLE 7 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)

TABLE 8 NORTH AMERICA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 9 NORTH AMERICA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)

TABLE 10 NORTH AMERICA TISSUE EXPANDERS IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 11 NORTH AMERICA IMPLANTS ACCESSORIES IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 12 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TECHNOLOGY, 2014-2028 (USD MILLION)

TABLE 13 NORTH AMERICA INFRAMAMMARY IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 14 NORTH AMERICA TRANS-AXILLARY IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 15 NORTH AMERICA PERI-AREOLAR IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 16 NORTH AMERICA TRANS UMBILLICAL IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 17 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY RECONSTRUCTION SHAPE, 2014-2028 (USD MILLION)

TABLE 18 NORTH AMERICA ROUND IMPLANT SHAPE IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 19 NORTH AMERICA ANATOMICAL IMPLANT SHAPE IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 20 NORTH AMERICA ROUND EXPANDER SHAPE IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 21 NORTH AMERICA ANATOMICAL EXPANDER SHAPE IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 22 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY PLACEMENT, 2014-2028 (USD MILLION)

TABLE 23 NORTH AMERICA DUAL-PLANE INSERTION IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 24 NORTH AMERICA SUBGLANDULAR INSERTION IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 25 NORTH AMERICA SUBMUSCULAR INSERTION IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 26 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY END USER, 2014-2028 (USD MILLION)

TABLE 27 NORTH AMERICA HOSPITAL IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 28 NORTH AMERICA CLINIC IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 29 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 30 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY DISTRIBUTION CHANNEL, 2014-2028 (USD MILLION)

TABLE 31 NORTH AMERICA DIRECT TENDER IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 32 NORTH AMERICA RETAIL SALES IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)

TABLE 33 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY COUNTRY, 2014-2028 (USD MILLION)

TABLE 34 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)

TABLE 35 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)

TABLE 36 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)

TABLE 37 NORTH AMERICA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)

TABLE 38 NORTH AMERICA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)

TABLE 39 NORTH AMERICA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)

TABLE 40 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TECHNOLOGY, 2014-2028 (USD MILLION)

TABLE 41 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY RECONSTRUCTION SHAPE, 2014-2028 (USD MILLION)

TABLE 42 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY PLACEMENT, 2014-2028 (USD MILLION)

TABLE 43 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY END USER, 2014-2028 (USD MILLION)

TABLE 44 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY DISTRIBUTION CHANNEL, 2014-2028 (USD MILLION)

TABLE 45 U.S. BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)

TABLE 46 U.S. BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)

TABLE 47 U.S. BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)

TABLE 48 U.S. BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)

TABLE 49 U.S. BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)

TABLE 50 U.S. BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)

TABLE 51 U.S. BREAST RECONSTRUCTION MARKET, BY TECHNOLOGY, 2014-2028 (USD MILLION)

TABLE 52 U.S. BREAST RECONSTRUCTION MARKET, BY RECONSTRUCTION SHAPE, 2014-2028 (USD MILLION)

TABLE 53 U.S. BREAST RECONSTRUCTION MARKET, BY PLACEMENT, 2014-2028 (USD MILLION)

TABLE 54 U.S. BREAST RECONSTRUCTION MARKET, BY END USER, 2014-2028 (USD MILLION)

TABLE 55 U.S. BREAST RECONSTRUCTION MARKET, BY DISTRIBUTION CHANNEL, 2014-2028 (USD MILLION)

TABLE 56 CANADA BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)

TABLE 57 CANADA BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)

TABLE 58 CANADA BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)

TABLE 59 CANADA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)

TABLE 60 CANADA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)

TABLE 61 CANADA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)

TABLE 62 CANADA BREAST RECONSTRUCTION MARKET, BY TECHNOLOGY, 2014-2028 (USD MILLION)

TABLE 63 CANADA BREAST RECONSTRUCTION MARKET, BY RECONSTRUCTION SHAPE, 2014-2028 (USD MILLION)

TABLE 64 CANADA BREAST RECONSTRUCTION MARKET, BY PLACEMENT, 2014-2028 (USD MILLION)

TABLE 65 CANADA BREAST RECONSTRUCTION MARKET, BY END USER, 2014-2028 (USD MILLION)

TABLE 66 CANADA BREAST RECONSTRUCTION MARKET, BY DISTRIBUTION CHANNEL, 2014-2028 (USD MILLION)

TABLE 67 MEXICO BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)

TABLE 68 MEXICO BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)

TABLE 69 MEXICO BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)

TABLE 70 MEXICO BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)

TABLE 71 MEXICO BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)

TABLE 72 MEXICO BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)

TABLE 73 MEXICO BREAST RECONSTRUCTION MARKET, BY TECHNOLOGY, 2014-2028 (USD MILLION)

TABLE 74 MEXICO BREAST RECONSTRUCTION MARKET, BY RECONSTRUCTION SHAPE, 2014-2028 (USD MILLION)

TABLE 75 MEXICO BREAST RECONSTRUCTION MARKET, BY PLACEMENT, 2014-2028 (USD MILLION)

TABLE 76 MEXICO BREAST RECONSTRUCTION MARKET, BY END USER, 2014-2028 (USD MILLION)

TABLE 77 MEXICO BREAST RECONSTRUCTION MARKET, BY DISTRIBUTION CHANNEL, 2014-2028 (USD MILLION)

图片列表

FIGURE 1 NORTH AMERICA BREAST RECONSTRUCTION MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA BREAST RECONSTRUCTION MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA BREAST RECONSTRUCTION MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA BREAST RECONSTRUCTION MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA BREAST RECONSTRUCTION MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA BREAST RECONSTRUCTION MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA BREAST RECONSTRUCTION MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA BREAST RECONSTRUCTION MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 NORTH AMERICA BREAST RECONSTRUCTION MARKET: SEGMENTATION

FIGURE 10 NORTH AMERICA BREAST RECONSTRUCTION MARKET: MARKET END USER COVERAGE GRID

FIGURE 11 GROWING AWARENESS ABOUT RECONSTRUCTIVE BREAST SURGERIES IS EXPECTED TO DRIVE THE NORTH AMERICA BREAST RECONSTRUCTION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 BREAT IMPLANTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA BREAST RECONSTRUCTION MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF NORTH AMERICA BREAST RECONSTRUCTION MARKET

FIGURE 14 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TYPE, 2020

FIGURE 15 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TYPE, 2014 TO 2028 (USD MILLION)

FIGURE 16 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 17 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TYPE, LIFELINE CURVE

FIGURE 18 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TECHNOLOGY, 2020

FIGURE 19 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TECHNOLOGY, 2014 TO 2028 (USD MILLION)

FIGURE 20 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TECHNOLOGY, CAGR (2021-2028)

FIGURE 21 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TECHNOLOGY, LIFELINE CURVE

FIGURE 22 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY RECONSTRUCTION SHAPE, 2020

FIGURE 23 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY RECONSTRUCTION SHAPE, 2014 TO 2028 (USD MILLION)

FIGURE 24 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY RECONSTRUCTION SHAPE, CAGR (2021-2028)

FIGURE 25 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY RECONSTRUCTION SHAPE, LIFELINE CURVE

FIGURE 26 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY PLACEMENT, 2020

FIGURE 27 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY PLACEMENT, 2014 TO 2028 (USD MILLION)

FIGURE 28 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY PLACEMENT, CAGR (2021-2028)

FIGURE 29 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY PLACEMENT, LIFELINE CURVE

FIGURE 30 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY END USER, 2020

FIGURE 31 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY END USER, 2014 TO 2028 (USD MILLION)

FIGURE 32 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY END USER, CAGR (2021-2028)

FIGURE 33 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY END USER, LIFELINE CURVE

FIGURE 34 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 35 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY DISTRIBUTION CHANNEL, 2014 TO 2028 (USD MILLION)

FIGURE 36 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 37 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 38 NORTH AMERICA BREAST RECONSTRUCTION MARKET: SNAPSHOT (2020)

FIGURE 39 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY COUNTRY (2020)

FIGURE 40 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY COUNTRY (2021 & 2028)

FIGURE 41 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY COUNTRY (2020 & 2028)

FIGURE 42 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TYPE (2021-2028)

FIGURE 43 NORTH AMERICA BREAST RECONSTRUCTION MARKET: COMPANY SHARE 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The North America Aesthetic and Cosmetic Surgery Devices Market size will be worth USD 1,985.42 million by 2028.
The North America Aesthetic and Cosmetic Surgery Devices Market growth rate will be 7.0% by 2028.
The Increasing usage of aesthetic & cosmetic surgery devices products, the growing geriatric populace are the growth drivers of the North American Aesthetic and Cosmetic Surgery Devices Market.
The type, raw material, end user, and distribution channel are the factors on which the North America Aesthetic and Cosmetic Surgery Devices Market research is based.
The major companies in the North America Aesthetic and Cosmetic Surgery Devices Market are Johnson & Johnson Services, Inc., Allergan (A Subsidiary of abbvie INC.), Airxpanders, Inc., Bonashmedical, Cereplas, Coloplast Corp, DPS Technology Development Ltd, Establishment Labs S.A., GC Aesthetics, Hansbiomed co. Ltd, Ideal Implant Incorporated, Implantech, Koken Co., Ltd., Laboratoires Arion, PMT Corporation, Polytech Health & Aesthetics Gmbh, Rigicon Inc., Sebbin, Shanghai Kangning Medical Supplies Ltd., Sientra, Inc., Silimed, Stryker, Surgisil LLP, Wanhe, Xilloc Medical B.V., Integra Lifesciences, Lipoelastic A.S., Defygravity, and Karl Storz Se.